| Income Statement |
| Total Revenue | 1.53M |
|
| Revenues (USD) | 1.53M |
| Gross Profit | 1.53M |
| Operating Expenses | 19.37M |
| Research and Development Expense | 11.26M |
| Selling, General and Administrative Expense | 8.12M |
| Operating Income | -17.84M |
| Interest Expense | 1.32M |
| Net Income | -19.18M |
| Net Income Common Stock | -19.18M |
| Net Income Common Stock (USD) | -19.18M |
| Consolidated Income | -19.18M |
| Earnings per Basic Share | -0.06 |
| Earnings per Basic Share (USD) | -0.06 |
| Earnings per Diluted Share | -0.06 |
| Earning Before Interest & Taxes (EBIT) | -17.86M |
| Earning Before Interest & Taxes (USD) | -17.86M |
| Weighted Average Shares | 327.54M |
| Weighted Average Shares Diluted | 327.54M |
| Balance Sheet |
| Cash and Equivalents | 32.17M |
| Cash and Equivalents (USD) | 32.17M |
| Current Assets | 38.55M |
| Property, Plant & Equipment Net | 13.83M |
| Total Assets | 56.91M |
| Debt Current | 5.86M |
| Total Debt | 33.30M |
| Current Liabilities | 20.71M |
| Debt Non-Current | 27.44M |
| Total Liabilities | 51.10M |
| Accumulated Retained Earnings (Deficit) | -427.24M |
| Accumulated Other Comprehensive Income | 164.00K |
| Shareholders Equity | 5.81M |
| Shareholders Equity (USD) | 5.81M |
| Assets Non-Current | 18.35M |
| Total Debt (USD) | 33.30M |
| Liabilities Non-Current | 30.39M |
| Trade and Non-Trade Payables | 3.24M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 913.00K |
| Net Cash Flow from Financing | 34.98M |
| Net Cash Flow / Change in Cash & Cash Equivalents | 13.29M |
| Capital Expenditure | -6.00K |
| Issuance (Purchase) of Equity Shares | 35.81M |
| Net Cash Flow from Investing | -6.00K |
| Net Cash Flow from Operations | -21.79M |
| Effect of Exchange Rate Changes on Cash | 102.00K |
| Share Based Compensation | 3.40M |